System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

IMCR

$30.86-0.58%

Immunocore Holdings plc

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

40Neutral

Live Analysis Active

Company Mission

Immunocore creates innovative cancer treatments called T-cell receptor therapies. These drugs work by training the body's own immune cells to recognize and attack cancer cells specifically. The company makes money by selling approved treatments to hospitals and clinics, and through partnerships with larger pharmaceutical companies to develop new therapies. Patients with certain types of cancer use these treatments when other options haven't worked.

IMC

Industry Context

Immunocore operates in the biotechnology sector, which focuses on developing treatments using biological systems. This industry is highly research-intensive with companies spending years developing new therapies before they can generate revenue from approved drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

85Matrix

Market Momentum

39.8— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-0.58%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IMCR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:35 PM UTC

As-of 03-14-2026 18:19 UTC

Develops cancer treatments that use the immune system to fight tumors and makes money by selling these drugs to hospitals and clinics.

Price below key moving averages, suggesting a downtrend as sellers have controlled momentum over recent weeks showing consolidation pattern.

Technical squeeze detected near current levels, indicating potential breakout when price volatility expands from this tight range, suggesting tight.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...